6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mutations in components of the molecular motor dynein/dynactin lead to neurodegenerative diseases of the motor system or atypical parkinsonism. These mutations are associated with prominent accumulation of vesicles involved in autophagy and lysosomal pathways, and with protein inclusions. Whether alleviating these defects would affect motor symptoms remain unknown. Here, we show that a mouse model expressing low levels of disease linked-G59S mutant dynactin p150(Glued) develops motor dysfunction >8 months before loss of motor neurons or dopaminergic degeneration is observed. Abnormal accumulation of autophagosomes and protein inclusions were efficiently corrected by lowering dietary protein content, and this was associated with transcriptional upregulations of key players in autophagy. Most importantly this dietary modification partially rescued overall neurological symptoms in these mice after onset. Similar observations were made in another mouse strain carrying a point mutation in the dynein heavy chain gene. Collectively, our data suggest that stimulating the autophagy/lysosomal system through appropriate nutritional intervention has significant beneficial effects on motor symptoms of dynein/dynactin diseases even after symptom onset.

          Related collections

          Author and article information

          Journal
          Hum. Mol. Genet.
          Human molecular genetics
          1460-2083
          0964-6906
          Apr 15 2015
          : 24
          : 8
          Affiliations
          [1 ] Department of Neurology.
          [2 ] Inserm U1118, Mécanismes Centraux et Périphériques de la Neurodégénérescence, Strasbourg F-67085, France, Université de Strasbourg, Fédération de Médecine Translationnelle (FMTS), UMRS1118, Strasbourg F-67085, France.
          [3 ] CNS Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany.
          [4 ] Translational Neuroendocrine Research Unit, Department of Experimental Medical Sciences, Lund University, 22184 Lund, Sweden and.
          [5 ] Central Facility for Electron Microscopy, Ulm University, 89081 Ulm, Germany.
          [6 ] Department of Pathology and Neuroscience and Division of Neuropathology, The Johns Hopkins University School of Medicine, Baltimore, USA.
          [7 ] Inserm U1118, Mécanismes Centraux et Périphériques de la Neurodégénérescence, Strasbourg F-67085, France, Université de Strasbourg, Fédération de Médecine Translationnelle (FMTS), UMRS1118, Strasbourg F-67085, France, ldupuis@unistra.fr.
          Article
          ddu741
          10.1093/hmg/ddu741
          4447824
          25552654
          1cee6528-d3f7-49cc-8083-2943da53e49e
          © The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
          History

          Comments

          Comment on this article